Sagent launches Cefazolin injection
SCHAUMBURG -- Sagent Pharmaceuticals Inc., a privately-held specialty pharmaceutical company, Thursday launched Cefazolin for injection, an antibiotic used to treat serious infections. The launch of Cefazolin for injection follows Sagent's December introduction of the first full-line of latex-free, multi-source, pre-filled, ready-to-use adenosine syringes. Sagent will begin marketing and shipping Cefazolin immediately.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.